亚特拉宁素A和B的总合成
Sarah A French1, Christopher J Sumby1, David M Huang1
1Department of Chemistry, The University of Adelaide, Adelaide, SA 5005, Australia.
Journal of the American Chemical Society
|December 12, 2022
概括
本研究呈现了A和B的仿生总合成,通过一种新的生物合成假设解释了它们的血细胞性质. 关键反应包括迪尔斯-阿尔德和循环加法,产生复杂的多环结构.
科学领域:
- 有机化学
- 自然产品合成
- 生物合成
背景情况:
- 氨酸A和B是具有复杂多环结构的天然产物.
- 它们的生物合成途径和它们的血质性质的原因以前是不清楚的.
研究的目的:
- 为了实现A和B的生物仿真总合成.
- 阐明这些化合物的生物合成起源并解释观察到的血性质.
主要方法:
- 这种合成采用了氨酸和E-β-ocimene之间的分子间Diels-Alder反应.
- 内分子 (3 + 2) 循环添加和晚期有氧氧化是关键的步骤.
- 一个模型系统被用来探索不同的转换.
主要成果:
- 达到了A和B的生物仿真总合成.
- 合成途径为化合物的血清性质提供了机理性的解释.
- 产生了复杂的多环基支架,并提出对阿特拉宁C的结构修订.
结论:
- 拟议的生物合成假设和生物模拟合成为阿特拉宁的形成提供了洞察力.
- 这项研究阐明了这些天然产品的结构方面和合成可用性.
- 这项工作为进一步探索相关的自然产品及其生物合成提供了基础.
相关概念视频
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.3K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.2K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.2K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.3K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.3K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K
Adrenergic Receptors: ɑ Subtype
1.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.7K
Adrenergic Receptors: β Subtype
1.8K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.8K


